Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX)
7.6500
+0.00 (0.00%)
NASDAQ · Last Trade: May 15th, 8:01 AM EDT
Detailed Quote
Previous Close
7.650
Open
-
Bid
7.010
Ask
7.140
Day's Range
N/A - N/A
52 Week Range
5.010 - 54.95
Volume
8,109
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
478,281
Chart
About Quoin Pharmaceuticals, Ltd. - American Depositary Shares (QNRX)
Quoin Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for rare and specialty diseases. The company specializes in creating and advancing treatments that address unmet medical needs, particularly in the areas of dermatology and other niche therapeutic segments. Through its research and development efforts, Quoin aims to provide effective solutions that improve patient outcomes and enhance the quality of life for those affected by challenging health conditions. The company's approach combines scientific expertise with a commitment to bringing new medications to market, fostering collaborations within the healthcare community to drive forward its mission. Read More
The stock closed up 20% on Wednesday, driven by promising patient outcomes and no reported adverse events for its Pediatric Peeling Skin Syndrome (PSS) drug, with further treatment and evaluations planned.
Today’s pre-market spotlight highlights a powerful mix of emerging growth companies driving innovation across key sectors including AI-powered Insurtech, mmWave wireless connectivity, smart wearables, clinical-stage biotech, and advanced weight loss solutions. From Health In Tech’s (NASDAQ: HIT) disruptive insurance platform to Peraso’s (NASDAQ: PRSO) wireless technology milestone, Allurion’s (NASDAQ: ALUR) FDA-ready program, Septerna’s (NYSE: SEPN) GPCR-based therapeutics, Quoin’s (NASDAQ: QNRX) progress in rare skin disease treatment and Innovative Eyewear’s (NASDAQ: LUCY) Smart Branded eyewear, these companies represent pivotal trends shaping the market in 2025. As investors seek early exposure to transformative technologies, these pre-market movers warrant close attention.
Shares of Quoin Pharmaceuticals surged 47.5% Wednesday morning. The stock is higher following the release of promising initial data from its ongoing clinical study of QRX003.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
